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Objective: To evaluate and practically demonstrate the inﬂuence of Althaea ofﬁcinalis
ﬂower mucilage as a plant known in Iran's and other Middle Eastern countries' traditional
medicine for its wound healing properties.
Methods: Animals were divided into 6 groups of 5 cases including a non-treated group
as the negative control group receiving no treatment, a group treated with eucerin as the
positive control group, a phenytoin 1% group as a standard group treated topically with
phenytoin 1% hand-made ointment, and treatment groups treated with hand-made
Althaea ofﬁcinalis ﬂower mucilage (AFM) ointment in a eucerin base with different
concentrations (5%, 10%, 15%).
Results: Among the treatment groups, the AFM 15% ointment showed the best result.
Wound healing duration was reduced by the surface application of these groups. Wound
closure was completed on Days 14 and 15 in the AFM 15% ointment and phenytoin 1%
groups, respectively. No signiﬁcant difference was observed in healing period between
these groups.
Conclusions: In conclusion, AFM 15% ointment was found to reduce wound healing
time without any signiﬁcant difference with the phenytoin 1% ointment. The authors
suggest increased AFM effectiveness in when combined with phenytoin or other effectual
plants.1. Introduction
Wound is deﬁned as any anatomical and physiological
disruption in skin structure leading to skin cell damage [1].
Thereby, wound healing is a complex and overlapping process
of reaction and interaction among cells and mediators to return
natural skin ability, beginning immediately after skin loss.
Inﬂammation proliferation and remodeling are three
overlapping and continuous wound healing phases [2].
Immediately after injury in the ﬁrst stage of homeostasis,
vascular constriction and clot formation caused by ﬁbrin andplatelets stop the bleeding [3,4]. Platelets release growth factors
and attract neutrophil macrophage, and other inﬂammatory
cells into the wound site. These cells kill microbes, break
wound debris, secrete cytokines and produce reactive oxygen
species [5,6]. Macrophage and ﬁbroblast cells become
dominant in this phase.
The second stage, the proliferation phase, is characterized by
re-epithelialization angiogenesis and proliferation. Fibroblasts
increase prominently and produce collagen and other extracel-
lular matrix components such as proteoglycans and glycosami-
noglycans. Collagen, as a basic structure of the granulation
tissue, increases prominently in this phase. The organization of
new vascular networks in the angiogenesis pathway stimulated
by macrophage activity, tissue hypoxia and vascular endothe-
lium growth factor (VEGF), provides necessary oxygen and
nutrient supplements required for wound repair. The wound area
is then epithelialized by keratinocytes. The healing process
completes in the remodeling phase, during which the skin
regains 80% of its original strength. Many factors can interferean open access article under the CC BY-NC-ND
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functionality. These factors include infection, age, sex hor-
mones, stress, obesity, and diabetes [7–10].
Individual factors such as stress or diabetes can cause delays
in the healing process or increase the risk of infection in the
wound. In 1939, Kimball found gingival hyperplasia to be the
most obvious side effect in patients treated with phenytoin.
Later, other researchers also used phenytoin to improve the
wound healing process [11]. Nowadays, phenytoin has become
the most common wound healing cream in drugstores in Iran.
Today, the healing properties of phytomedicine have become
widely accepted [12].
The choice of plant to use for wound treatments greatly de-
pends on numerous factors including skin structure, wound
healing processes, substances that accelerate healing and plant
components [13]. Althaea ofﬁcinalis (A. ofﬁcinalis), which is
used as an emollient, diuretic, anti-inﬂammatory, anti-
infective’and immunomodulator remedy, is a very popular
plant in Iranian traditional medicine (ITM) [14–16]. Al-Snaﬁ
analyzed Althaea for its components and maintained that it
can have very practical health beneﬁts [17]. According to ITM
experts, A. ofﬁcinalis has many therapeutic characteristics
including its anti-inﬂammatory and antibacterial effects and its
application as an immunomodulator. The main goal of the pre-
sent study was to determine the wound healing efﬁcacy of
Althaea ofﬁcinalis ﬂower mucilage (AFM) formulated in 5%,
10%, and 15% eucerin bases with special attention given to its
histological differentiation.
2. Materials and methods
Dried A. ofﬁcinalis (marshmallow) ﬂowers can be obtained
from local stores. In order to acquire mucilage from dried A.
ofﬁcinalis powder, we dissolved 20 g ground powder in 500 mL
boiled water. This mixture was then heated for 30 min at 70–
75 C and ﬁltered twice. The liquid mucilage was subsequently
heated using the bain marie method at 75 C for 24–42 h. After
the solvent evaporated, dried mucilage was carved with a
scalpel. To prepare the AFM ointment with different concen-
trations, 5, 10 and 15 g ground dried mucilage was mixed with a
eucerin base.
2.1. Preparation of animals
Thirty adult male and female New Zealand breed rabbits
weighing 1.6–2.2 kg were obtained from the Razi Institute of
Ahvaz. Rabbits were kept at (23 ± 2) C in a light cycle of 12 h
light and 12 h darkness, and fed with compact food made from
Shushtar Pars Company, vegetables, and water ad libitum.
Thirty rabbits were divided into six experimental groups (n = 5)
as follows: no treatment group, treatment with 1% phenytoin
ointment, treatment with AFM 5% ointment, treatment with
AFM 10% ointment, and treatment with AFM 15% ointment.
2.2. Wound induction method
First, the hair of the test animals' left side lower back was
completely shaved. The animals were situated to stay in the
standard crouching position. A metal template measuring
20 × 20 mm2, whose outline was traced by a ﬁne-tipped pen,
was placed on the stretched skin of each animal's lower back.The wound areas were anesthetized by 2% lidocaine subcu-
taneous injection on the square corners and sterilized using
betadine. Full thickness wounds were made by bistouries
blades, forceps, and kukher scissors. A draft was drawn around
each wound site by transparent plastic sheets and ﬁne tipped pen
marks. Sterilized wounds were washed with normal saline and
betadine immediately. The animals were kept in individual
cages after dressing and returned to their standard situation
[temperature of (23 ± 2) C, humidity of (50%–55%)]. Topical
ointments (eucerin, phenytoin in eucerin base and 5%, 10%,
15% concentrations of AFM in eucerin base) were applied on
wound sites twice a day. To reduce infection rate, wound sites
were evaluated daily for infection. All dressings and animal
maintenance followed the ethical rules of standard surgery
processes.
2.3. Method of wound area calculation
Wound area was calculated using graph paper. Healing
processes were found to be dependent on general (oxygenation,
nutrition and infection) and individual (sex hormones, obesity,
and age) factors. Although we tried to create equal situations to
minimize differences, the effect of individual characteristics was
undeniable in the healing process. To minimize errors in the
measurement of the wound area as well as achieve statistically
sound results, wound healing percentage was replaced with
wound area and calculated as follows:
Woundhealing percentage inNday
=
ðWound area in first day−Woundarea inNth dayÞ
Wound area in first day
×100
Precise interpretations of tissue samples required detailed
sampling; therefore, after anesthesia with 2% lidocaine subcu-
taneous injection, two triangular areas were separated from the
corners of the wound site to be histologically evaluated on Day 7
at the end of treatment. The tip of each triangle was treated and
the base was left untouched. Samples were ﬁxed in 10%
formalin and delivered to the Pathology Laboratory. Sample
preparation and interpretation were carried out by pathology
experts from Shafa Hospital and faculty members of the
Department of Veterinarian Sciences, Shahid Chamran Univer-
sity, Ahvaz, Iran. Hematoxylin and eosin (H & E) coloring was
used for tissue coloring.
2.4. Statistical analysis
Healing percentage was considered as healing factor between
the groups. After data collection, a One-way ANOVA and
Tukey tests were run. Each point in the diagrams showed the
mean ± SEM, and P < 0.05 was considered as signiﬁcant.
3. Results
In the non-treatment and eucerin groups, the wound healed
within 21 days. For those treated with 1% phenytoin in the
eucerin base, 15 days were required. The AFM ointment with
different concentrations of 5%, 10% and 15%, improved healing
in 17, 16 and 14 days, respectively. The healing percentage in
different groups on different days was analyzed through a
One-way ANOVA and Tukey's test. Healing percentage was
Figure 3. Wound healing proﬁle of AFM 5%-treated and eucerin-treated
groups.
*: P < 0.05, **: P < 0.01.
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eucerin-treated groups (Figure 1). Figure 2 shows the compari-
son between the 1% phenytoin and eucerin healing ability and
the signiﬁcant difference observed.
As shown in Figure 3, compared to the eucerin-treated group,
the healing percentage in the 5% AFM ointment group was
signiﬁcantly different at Day 11. Figure 4 shows that the 10%
AFM ointment group was signiﬁcantly different from the
eucerin-treated group.
Figure 5 shows the AFM 15% treated and the eucerin treated
groups compared. In Figure 5, signiﬁcant differences were
observed in the healing percentage from the ﬁrst day of wound
development.
Figure 6 shows the comparison between the AFM 15% and
1% phenytoin and signiﬁcant differences were observed in the
healing percentage from the 3rd day.
As indicated by the results of Day 14 with the short treat-
ment, different AFM concentrations (5%, 10%, 15%) and the
1% phenytoin groups showed signiﬁcant differences from the
eucerin treated group.
3.1. Histological assay
Having a precise interpretation of tissue samples required for
the detailed sampling, two triangle samples were separated
carefully from the corner of the wound sites on the 7th and ﬁnal
treatment days. Samples were ﬁxed in 10% formalin solution
and delivered to the Pathology Laboratory. H & E coloring was
selected for tissue coloring. Tissue sample preparations were
done in the Department of Pathology, Shafa Hospital, Ahvaz,
Iran. Pictures were taken from tissue samples by lightFigure 2. Wound healing proﬁle of 1%-treated and eucerin-treated groups.
*: P < 0.05, **: P < 0.01.
Figure 4. Wound healing proﬁle of AFM 10%-treated and eucerin-treated
groups.
*: P < 0.05, **: P < 0.01.
Figure 1. Wound healing proﬁle of non-treated and eucerin-treated groups.microscopy in the Department of Pathology, School of Veteri-
narian Sciences, Shahid Chamran University, Ahvaz, Iran.
3.1.1. Non-treated group
In the 7th day, wide ulcers were observed in the epidermis
layer. The accumulation of inﬂammation cells was seen in the
dermis layer, while granulation tissues were not seen in the 7th
day (Figure 7). At the end of treatment (Day 21), epidermisFigure 5. Wound healing proﬁle of AFM 15%-treated and eucerin-treated
groups.
*: P < 0.05, **: P < 0.01.
Figure 6. Wound healing proﬁle of 1% phenytoin-treated and AFM 15%-
treated groups.
*: P < 0.05, **: P < 0.01.
Figure 7. Tissue sample of wound site in non-treated group on Day 7
(H & E, × 100).
E: Epidermis; U: Ulcer; I: Inﬂammation cells.
Figure 9. Tissue sample of wound site in eucerin treated group on Day 7
(H & E, × 100).
E: Epidermis; U: Ulcer; G: Granulation tissue; D: Dermis.
Figure 10. Tissue sample of wound site in eucerin treated group on Day 21
(H & E, × 200).
E: Epidermis; G: Granulation tissue; I: Inﬂammation cells.
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were observed in this group (Figure 8).
3.1.2. Eucerin-treated group
At the 7th day, epidermis renovation began, but ulcers were
observed in the wound site and ﬁbroblast cells proliferation and
granulation tissues formed in the dermis layer (Figure 9).Figure 8. Tissue sample of healed wound in non-treated group on Day 21
(H & E, × 100).
E: Epidermis; G: Granulation tissue; I: Inﬂammation cells.In the ﬁnal day, when wound size reduced to zero, the
epidermis was formed completely; accumulation inﬂammatory
cells were observed and ﬁbroblast proliferation with initial
granulation tissue was formed (Figure 10).
3.1.3. 1% Phenytoin ointment-treated group
Debris tissue and epidermis formation were clearly observed
at Day 7. Fibroblast proliferation showed the initial process of
granulation tissue formation (Figure 11).
Epidermis regenerated completely at the end of the treatment,
and proliferated ﬁbroblast and precipitated collagen were
observed. Dermis restoration was also evident (Figure 12).Figure 11. Tissue sample of healed wound in 1% phenytoin treated group
on Day 7 (H & E, × 200).
E: Epidermis; G: Granulation tissue; S: Scar.
Figure 12. Tissue sample of healed wound in 1% phenytoin treated group
on Day 15 (H & E, × 200).
E: Epidermis; D: Dermis.
Figure 14. Tissue sample of healed wound in 5% Althaea ointment treated
group on Day 16 (H & E, × 200).
E: Epidermis; G: Granulation tissue.
Figure 15. Tissue sample of healed wound in 10% Althaea ointment
treated group on Day 7 (H & E, × 200).
E: Epidermis; G: Granulation tissue.
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At Day 7, ulcers, necrotic tissues in the epidermis layer, in-
ﬂammatory cells and neutrophil accumulations were clearly
observed (Figure 13). In the ﬁnal day of treatment, epidermis
formation was completed, and granulation tissues, maturated
ﬁbroblast cells and collagen deposition were seen (Figure 14).
3.1.5. 10% AFM ointment-treated group
At Day 7, the epidermis was passing through the initial
repairing process, and granulation tissues and neutrophil cells in
histological assays were clearly observed (Figure 15). At the end
of treatment, epidermis formation was completed and sedimen-
tary collagen, proliferated ﬁbroblast, and granulation tissues
were seen (Figure 16).
3.1.6. 15% AFM ointment-treated group
At Day 7, new epidermis was formed under the debris tissue
and an irritation reaction was seen in the dermis (Figure 17). On
the 14th day, the epidermis layer was seen with normal thickness
in the histological assay, and ﬁbroblast proliferation and gran-
ulation tissue formation in the dermis layer were observed
(Figure 18).
3.2. Histological result
The 15% AFM ointment made perfect repair in a macro-
scopic analysis 14 days after the treatment (the shortest timeFigure 13. Tissue sample of healed wound in 5% Althaea ointment treated
group on Day 7 (H & E, × 200).
E: Epidermis; U: Ulcer; I: Inﬂammation cells.between groups). At the end of the treatment, when complete
healing was observed in the macroscopic evaluation, different
groups were evaluated for epidermis thickness; new blood ves-
sels were found in the angiogenesis process. In addition, ﬁbro-
blast numbers increased and maturation and collagen
precipitation were also formed. In the eucerin and non-treatment
groups, inﬂammation reactions were seen in the macroscopic
evaluation, despite being at the end of the treatment. Fibroblasts
were observed in the microscopic analysis, which was also the
same for other treatment groups (1% phenytoin and 5%, 10%,
15% AFM ointments). No inﬂammation reaction was observed.
Fibroblast number decreased due to the anti-inﬂammatory effect
in these groups. Collagen precipitation was observed as aFigure 16. Tissue sample of healed wound in 10% Althaea ointment
treated group on Day 17 (H & E, × 100).
E: Epidermis; G: Granulation tissue; D: Dermis.
Figure 18. Tissue sample of healed wound in 15% Althaea ointment
treated group on Day14 (H & E, × 100).
E: Epidermis; G: Granulation tissue; D: Dermis.
Figure 17. Tissue sample of healed wound in 15% Althaea ointment
treated group on Day 7 (H & E, × 100).
E: Epidermis; I: Inﬂammation tissue; S: Scar.
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day. Angiogenesis was clearly observed in the picture with a
200× resolution. The 1% phenytoin and the 15% AFM oint-
ments showed higher healing rates. In the 15% AFM group on
Days 3–9, little difference was observed in the ﬁnal epidermis
thickness or collagen precipitation as compared to the ﬁnal day
of the treatment. In this study, perfect repair and ﬁnal day refer
to the wound site without any sign of infection, secretion or
blood vessels in the skin surface (blood vessels were seen in the
angiogenesis period in the incomplete repairs). In other words,
skin elasticity returned to its normal position, though scars might
have been observed in the wound site in light or dark areas a
long time after healing. The pathological picture evaluation of
treatment groups on the 7th day showed initial epithelialization
and epidermis formation in the 1% phenytoin and 15% AFM
groups. The epidermis in the eucerin-treated group was thicker
in the ﬁnal day of treatment (Day 21) compared with the A.
ofﬁcinalis of different concentrations or the 1% phenytoin
groups. This showed that longer periods and repairing times
with less speed could result in a thicker epidermis.
4. Discussion
Wound healing is a complex and continuous process that
begins immediately after injury. It is accompanied by homeo-
stasis blood clotting inﬂammation proliferation and remodeling
phases. All these processes can prolong or promote healing by
inﬂuencing external or internal factors including infection sex
hormones and nutrition. Today, the demand for herbal therapy isincreasing. Phytomedicine has a long history in herbal remedies.
A. ofﬁcinalis ﬂower is a famous plant in ITM characterized by its
anti-inﬂammatory immunomodulator and anti-infection proper-
ties. Al-Snaﬁ analyzed and detected A. ofﬁcinalis ﬂower com-
ponents and approved its remedial properties accordingly. The
components they detected include mucilage, pectin, tannin, ﬂa-
vonoids, phenolic acid, and other amino acids [17]. Li et al. in
their survival literature, argued that tannic acid can promote
excisional wound healing by angiogenesis and antibacterial
activities. They showed that tannic acid increased the VEGF
level [18–20]. VEGF is the most efﬁcacious, prevalent and long
term angiogenesis signal stimulator for wound sites. Tannin
and arabinose promote healing time through coagulating
surface proteins [20]. Pectin is another detected A. ofﬁcinalis
ﬂower substance that prepares moist and oxygen in the wound
site which is, in turn, a vital factor for angiogenesis and
epithelialization and kills bacteria in wound sites [21–23].
Researchers have found anti-oxidant agents to diminish the
increased level of reactive oxygen species in wound sites and to
minimize tissue damage resulting from hydrogen peroxide pro-
duction or oxygen free radicals in these sites [24]. Recently,
studies have reported mucilage (the major part of A. ofﬁcinalis
extract) to be a polysaccharide that stimulates the
epithelialization in the epithelial surface of the damaged tissue.
Phenolic acid in A. ofﬁcinalis has an anti-inﬂammatory effect
which helps reduce healing time. The weaker inﬂammatory re-
action in pathological samples of different concentrations of A.
ofﬁcinalis at the end of our treatment might be caused by this
compound [24,25].
Our initial ﬁndings regarding the wound healing process
showed a reduced healing time. In this study, the 15% AFM
ointment signiﬁcantly enhanced wound healing in rabbits and
reduced the days needed for complete healing compared with the
eucerin or non-treated groups; nevertheless, no signiﬁcant dif-
ference was found with the 1% phenytoin ointment treated
group. Thus, more investigations are required to elucidate the
exact effect of A. ofﬁcinalis ﬂower on wound healing.
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